130 related articles for article (PubMed ID: 34193687)
1. Dexmedetomidine Reduces the Lidocaine-Induced Neurotoxicity by Inhibiting Inflammasome Activation and Reducing Pyroptosis in Rats.
Ding XD; Cao YY; Li L; Zhao GY
Biol Pharm Bull; 2021; 44(7):902-909. PubMed ID: 34193687
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis.
Sun YB; Zhao H; Mu DL; Zhang W; Cui J; Wu L; Alam A; Wang DX; Ma D
Cell Death Dis; 2019 Feb; 10(3):167. PubMed ID: 30778043
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine exerts a protective effect on ischemic brain injury by inhibiting the P2X7R/NLRP3/Caspase-1 signaling pathway.
Sun K; Zhang J; Yang Q; Zhu J; Zhang X; Wu K; Li Z; Xie W; Luo X
Brain Res Bull; 2021 Sep; 174():11-21. PubMed ID: 33991606
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine ameliorates lidocaine-induced spinal neurotoxicity via inhibiting glutamate release and the PKC pathway.
Xu H; Zhao B; She Y; Song X
Neurotoxicology; 2018 Dec; 69():77-83. PubMed ID: 30240660
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ
Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841
[TBL] [Abstract][Full Text] [Related]
7. Melatonin ameliorates bupivacaine-induced spinal neurotoxicity in rats by suppressing neuronal NLRP3 inflammasome activation.
Lai J; Ji JM; Chen MY; Luo YP; Yu Y; Zhou G; Wei LL; Huang LS; Liu JC
Neurosci Lett; 2022 Feb; 772():136472. PubMed ID: 35065245
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats.
Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H
Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950
[TBL] [Abstract][Full Text] [Related]
10. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro.
Ma DC; Zhang NN; Zhang YN; Chen HS
J Ethnopharmacol; 2021 Apr; 270():113776. PubMed ID: 33421597
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting NLRP3.
Peng J; Zhang P; Zheng H; Ren YQ; Yan H
Chin J Traumatol; 2019 Jun; 22(3):161-165. PubMed ID: 31056470
[TBL] [Abstract][Full Text] [Related]
12. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling.
Liu Z; Tu K; Zou P; Liao C; Ding R; Huang Z; Huang Z; Yao X; Chen J; Zhang Z
Int Immunopharmacol; 2023 May; 118():110103. PubMed ID: 37001385
[TBL] [Abstract][Full Text] [Related]
13. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats.
Dai W; Wang X; Teng H; Li C; Wang B; Wang J
Int Immunopharmacol; 2019 Jan; 66():215-223. PubMed ID: 30472522
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.
Zheng LN; Guo FQ; Li ZS; Wang Z; Ma JH; Wang T; Wei JF; Zhang WW
Hum Exp Toxicol; 2020 Sep; 39(9):1213-1223. PubMed ID: 32228195
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats.
Fu C; Dai X; Yang Y; Lin M; Cai Y; Cai S
Mol Med Rep; 2017 Jan; 15(1):131-138. PubMed ID: 27959438
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway.
Li J; Dou X; Li D; He M; Han M; Zhang H
J Invest Surg; 2020 Jul; 33(6):576-583. PubMed ID: 30913929
[No Abstract] [Full Text] [Related]
18. Dexmedetomidine protects against high mobility group box 1-induced cellular injury by inhibiting pyroptosis.
Ji X; Guo Y; Zhou G; Wang Y; Zhang J; Wang Z; Wang Q
Cell Biol Int; 2019 Jun; 43(6):651-657. PubMed ID: 30958608
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.
Zhao L; Zhai M; Yang X; Guo H; Cao Y; Wang D; Li P; Liu C
J Cell Mol Med; 2019 Dec; 23(12):8173-8183. PubMed ID: 31625681
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Lu Y; Lin B; Zhong J
Biol Pharm Bull; 2017 Sep; 40(9):1432-1438. PubMed ID: 28626198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
